Clinical Research Directory
Browse clinical research sites, groups, and studies.
NeuroCuple to Mitigate Post-Wisdom Teeth Extraction Opioid Risks
Sponsor: nCap Medical
Summary
This is a randomized (1:1), placebo-controlled clinical trial that will examine the feasibility and effectiveness of a 2-day application of the NeuroCuple device for pain relief and reduction of opioid use following wisdom teeth extraction. The primary objectives are to determine whether the active NeuroCuple reduces postoperative pain and decreases opioid consumption compared to a sham (placebo) device. A total of 120 participants will be enrolled over a 1-year period and randomized to receive either the active device or an identical-appearing placebo device without the captor array layer.
Official title: Mitigating Opioid Use Disorder Risk With Enhanced Opioid Sparing Pain Relief for Wisdom Teeth Extractions With a Novel Nanotechnology
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-06-30
Completion Date
2027-09-30
Last Updated
2026-03-31
Healthy Volunteers
No
Interventions
NEUROCUPLE™ Patch
nCAP Medical has developed an effective, safe, opioid-sparing, non-pharmacological analgesic device, NeuroCuple®, that can reduce opioid use and surgical pain.
Sham Patch
The sham patch is identical to the active patch but with no active agents.
Locations (1)
University of Pittsburgh School of Dental Medicine
Pittsburgh, Pennsylvania, United States